Zhengye Biotechnology Holding (ZYBT) Current Leases (2025)
Zhengye Biotechnology Holding's (ZYBT) quarterly Current Leases came in at $14945.2 in Q4 2025.
Powered by 
Analysis
Zhengye Biotechnology Holding (ZYBT) Current Leases (2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Current Leases for 1 consecutive years, with $14945.2 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Current Leases changed N/A year-over-year to $14945.2 in Q4 2025; TTM through Dec 2025 was $14945.2, a N/A change from a year earlier, with the FY2025 full-year figure at $15000.0, changed N/A from the prior year.
- Current Leases was $14945.2 for Q4 2025 at Zhengye Biotechnology Holding.
- Over five years, Current Leases peaked at $14945.2 in Q4 2025 and troughed at $14945.2 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.03 Bn | 39.83 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.51 Bn | 28.83 Bn | 1.05 Bn | - |
| 3 | Elanco Animal Health | 11.50 Bn | 10.97 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn | 10.57 Mn |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn | 121,858.00 |
| 6 | Zhengye Biotechnology Holding | 75.81 Mn | 68.71 Mn | - | 14,945.22 |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |